Pharmacology of Thyrotropin Releasing Factor (TRF), Luteinizing Hormone Releasing Factor (LRF), and Somatostatin
- 1 January 1977
- book chapter
- Published by Springer Nature
- Vol. 87, 123-156
- https://doi.org/10.1007/978-1-4615-8849-8_7
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Diazepam: Invitro effects on glucagon and insulin releaseBiochemical and Biophysical Research Communications, 1976
- Synthesis of a nonreducible cyclic analog of somatostatin having only growth hormone release inhibiting activityBiochemical and Biophysical Research Communications, 1976
- A novel cyclic undecapeptide, Wy-40,770, with prolonged growth hormone release inhibiting activityBiochemical and Biophysical Research Communications, 1976
- Presence of proline in positions 3 for potent inhibition of the activity of the luteinizing hormone releasing hormone and of ovulationBiochemical and Biophysical Research Communications, 1976
- Modification of pentobarbital effects by natural and synthetic polypeptides: Dissociation of brain and pituirary effectsLife Sciences, 1975
- Analogs of luteinizing hormone releasing factor (LRF) synthesis and biological activity of [(Nα-Me)Leu7]LRF and [D-Ala6,(Nα-Me)Leu7]LRFBiochemical and Biophysical Research Communications, 1975
- Enzymatic mechanisms for the inactivation of luteinizing hormone-releasing hormone (LH-RH)Biochemical and Biophysical Research Communications, 1974
- Enzymic degradation of luteinizing hormone-releasing hormone (LH-RH) by hypothalamic tissueBiochemical and Biophysical Research Communications, 1974
- Some analogs of luteinizing hormone releasing hormone (LH-RH) having intense ovulation-inducing activityBiochemical and Biophysical Research Communications, 1974
- Synthesis and biological properties of [D-Ala-6, des-Gly-NH2-10]-LH-RH ethylamide, a peptide with greatly enhanced LH- and FSH-releasing activityBiochemical and Biophysical Research Communications, 1974